StoneX Group
RGNX icon

StoneX Group’s Regenxbio RGNX Stock Holding History

StoneX Group’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$91.3K Buy
+10,759
New +$109K ﹤0.01% 1520

Other funds holding RGNX

JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $121B AUM 21.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

StoneX Group's RGNX Position: Q3 2026 in Review

StoneX Group opened a new position in Regenxbio (RGNX) in Q3 2026: 10,759 shares worth $91.3K. The stake represents ﹤0.01% of the portfolio and ranks #1520 among its holdings.

90 funds tracked by Wall St. Rank hold RGNX as of Q3 2026.

  • StoneX Group held 10,759 shares of Regenxbio worth $91.3K as of Q3 2026.
  • Regenxbio was a new StoneX Group position in Q3 2026.
  • Regenxbio made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1520 holding.
  • 90 funds tracked by Wall St. Rank held Regenxbio as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.